CDC7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.141600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.832600E-01
Normal-vs-Stage2
5.263800E-01
Normal-vs-Stage3
3.722800E-01
Normal-vs-Stage4
2.803800E-01
Stage1-vs-Stage2
9.868000E-01
Stage1-vs-Stage3
3.827600E-01
Stage1-vs-Stage4
5.078200E-01
Stage2-vs-Stage3
2.184800E-01
Stage2-vs-Stage4
3.194800E-01
Stage3-vs-Stage4
8.040400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.132600E-01
Normal-vs-AfricanAmerican
4.323600E-01
Normal-vs-Asian
5.065600E-01
Caucasian-vs-AfricanAmerican
5.542800E-01
Caucasian-vs-Asian
9.126200E-01
AfricanAmerican-vs-Asian
5.253800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.672200E-01
Normal-vs-Female
5.813800E-01
Male-vs-Female
1.361650E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.388400E-01
Normal-vs-Age(41-60Yrs)
5.533200E-01
Normal-vs-Age(61-80Yrs)
5.008400E-01
Normal-vs-Age(81-100Yrs)
5.443400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.585180E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.057400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.244200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.902400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.905800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.677000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.602000E-01
Normal-vs-Daily Drinker
4.863400E-01
Normal-vs-Weekly Drinker
4.513000E-01
Normal-vs-Occasional Drinker
4.997000E-01
Normal-vs-Social Drinker
4.968400E-01
Non Drinker-vs-Daily Drinker
6.696200E-01
Non Drinker-vs-Weekly Drinker
4.012200E-01
Non Drinker-vs-Occasional Drinker
5.508600E-01
Non Drinker-vs-Social Drinker
5.797400E-01
Daily Drinker-vs-Weekly Drinker
5.100200E-01
Daily Drinker-vs-Occasional Drinker
8.616000E-01
Daily Drinker-vs-Social Drinker
8.895400E-01
Weekly Drinker-vs-Occasional Drinker
5.691600E-01
Weekly Drinker-vs-Social Drinker
5.558400E-01
Occasional Drinker-vs-Social Drinker
9.730800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.140600E-01
Normal-vs-Grade 2
6.570800E-01
Normal-vs-Grade 3
6.542600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.729700E-02
Grade 1-vs-Grade 3
1.005650E-01
Grade 1-vs-Grade 4
6.140600E-01
Grade 2-vs-Grade 3
8.717000E-01
Grade 2-vs-Grade 4
6.570800E-01
Grade 3-vs-Grade 4
6.542600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.604200E-01
Normal-vs-NonDiabetic
5.057400E-01
Diabetic-vs-NonDiabetic
3.426800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.008200E-01
Normal-vs-NoPancreatitis
4.892400E-01
Pancreatitis-vs-NoPancreatitis
9.214000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.153000E-01
Normal-vs-N1
5.228000E-01
N0-vs-N1
8.710000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.870600E-01
Normal-vs-TP53-NonMutant
4.872800E-01
TP53-Mutant-vs-TP53-NonMutant
1.511600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
